Health Highlights: Feb. 20, 2017Last Updated: February 20, 2017.
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
NASA Sends 'Superbug' to the Space Station
A staph germ resistant to multiple antibiotics -- a so-called "superbug'' -- was planned to be sent via rocket to the International Space Station on Sunday.
According to CNN, NASA astronauts plan to study the methicillin-resistant Staphylococcus aureus (MRSA) germ in the unique zero-gravity environment of space, to better understand how these dangerous germs mutate around antibiotics.
MRSA is a common "superbug," responsible for tough-to-treat blood infections, plus pneumonias and skin infections.
"We are excited to put MRSA on the International Space Station [ISS] and investigate the effects of microgravity on the growth and mutation patterns of these bugs," Dr. Anita Goel said at a NASA news conference last week. She's a medical doctor, physicist and CEO of biomedicine company Nanobiosym.
"I have this hypothesis that microgravity will accelerate the mutation patterns," Goel explained. "If we can use microgravity as an accelerator to fast-forward and get a sneak preview of what these mutations will look like, then we can essentially build smarter drugs on Earth."
Prior research has shown that zero-gravity may help microbes grow faster.
"If indeed we can use the ISS as an accelerator, an incubator, to know what future mutations of superbugs like MRSA will be, we [can] use that info to develop better algorithms on Earth to inform drug discovery and faster ways to get to smarter drugs that are more personalized and more precisely targeted to a bug or strain at hand," Goel reasoned.
She added that rigid precautions are being taken to ensure that the astronauts aboard the space station cannot come into direct contact with the MRSA superbug.
|Previous: Health Tip: Stay Safe During Winter Sports||Next: Don't Punish Pregnant Women for Opioid Use, Docs Say|
Reader comments on this article are listed below. Review our comments policy.